These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6179600)
1. Prostatic hexosaminidase activity in patients with benign prostatic hyperplasia and prostatic carcinoma. Whitehurst GB; Mashburn JP; Pretlow TG; Bradley EL; Boohaker EA Cancer Res; 1982 Oct; 42(10):4300-3. PubMed ID: 6179600 [TBL] [Abstract][Full Text] [Related]
2. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma. Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588 [TBL] [Abstract][Full Text] [Related]
3. Decrease in creatine kinase in human prostatic carcinoma compared to benign prostatic hyperplasia. Pretlow TG; Whitehurst GB; Pretlow TP; Hunt RS; Jacobs JM; McKenzie DR; McDaniel HG; Hall LM; Bradley EL Cancer Res; 1982 Nov; 42(11):4842-8. PubMed ID: 6181869 [TBL] [Abstract][Full Text] [Related]
4. Alteration of hexosaminidase isozymes in human renal carcinoma. Okochi T; Seike H; Higashino K; Hada T; Watanabe S; Yamamura Y; Ito F; Matsuda M; Osafune M; Kotake T; Sonoda T Cancer Res; 1979 May; 39(5):1829-34. PubMed ID: 427815 [TBL] [Abstract][Full Text] [Related]
5. Enzyme activities in prostatic carcinoma related to Gleason grades. Pretlow TG; Harris BE; Bradley EL; Bueschen AJ; Lloyd KL; Pretlow TP Cancer Res; 1985 Jan; 45(1):442-6. PubMed ID: 3155494 [TBL] [Abstract][Full Text] [Related]
6. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues. Sharief FS; Mohler JL; Sharief Y; Li SS Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903 [TBL] [Abstract][Full Text] [Related]
7. Expression of protein kinase C isoenzymes in benign hyperplasia and carcinoma of prostate. Koren R; Ben Meir D; Langzam L; Dekel Y; Konichezky M; Baniel J; Livne PM; Gal R; Sampson SR Oncol Rep; 2004 Feb; 11(2):321-6. PubMed ID: 14719062 [TBL] [Abstract][Full Text] [Related]
8. [Expression of COX-2 in prostatic cancer and benign prostatic hyperplasia]. Zang T; Sun F; Li Y Zhonghua Wai Ke Za Zhi; 2001 Sep; 39(9):702-3. PubMed ID: 11769607 [TBL] [Abstract][Full Text] [Related]
13. The effect of manipulation of the prostate gland on serum prostate-specific acid phosphatase measured by radioimmunoassay. Vihko P; Lukkarinen O; Kontturi M; Vihko R Invest Urol; 1981 Mar; 18(5):334-6. PubMed ID: 6162819 [TBL] [Abstract][Full Text] [Related]
16. Analysis of prostatic fluid in prostatic disease. Grayhack JT; Wendel EF; Lee C; Oliver L Cancer Treat Rep; 1977; 61(2):205-10. PubMed ID: 68824 [TBL] [Abstract][Full Text] [Related]
17. Prostatic acid phosphatase levels (enzymatic method) from completely sectioned, clinically benign, whole prostates. Brawn PN; Jay DW; Foster DM; Kuhl D; Speights VO; Johnson EH; Riggs M; Lind ML; Coffield KS; Weaver B Prostate; 1996 May; 28(5):295-9. PubMed ID: 8610055 [TBL] [Abstract][Full Text] [Related]
18. 5 alpha-reductase activity in cultured epithelial and stromal cells from normal and hyperplastic human prostates--effect of finasteride (Proscar), a 5 alpha-reductase inhibitor. Boudon C; Lobaccaro JM; Lumbroso S; Lechevallier E; Mottet N; Gibelin B; Sultan C Cell Mol Biol (Noisy-le-grand); 1995 Dec; 41(8):1007-15. PubMed ID: 8747081 [TBL] [Abstract][Full Text] [Related]
19. Selectivity of finasteride as an in vivo inhibitor of 5alpha-reductase isozyme enzymatic activity in the human prostate. Span PN; Völler MC; Smals AG; Sweep FG; Schalken JA; Feneley MR; Kirby RS J Urol; 1999 Jan; 161(1):332-7. PubMed ID: 10037433 [TBL] [Abstract][Full Text] [Related]
20. beta-Hexosaminidase isozymes in human colonic carcinoma. Brattain MG; Kimball PM; Pretiow TG Cancer Res; 1977 Mar; 37(3):731-5. PubMed ID: 13928 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]